Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

69.85
Delayed Data
As of Feb 17
 -0.46 / -0.65%
Today’s Change
65.38
Today|||52-Week Range
103.10
-2.46%
Year-to-Date
Big pharma bets billions on 'silent' liver disease
12:08am / FT.com - Paid Partner Content
Why President Trump Should Buy Gilead Sciences
Feb 17 / MotleyFool.com - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 20 / TheStreet.com - Paid Partner Content
Your Burning Biotech Questions Answered
Feb 17 / TheStreet.com - Paid Partner Content
Why Gilead Sciences Is a Buy
Feb 19 / MotleyFool.com - Paid Partner Content
Thanks, Martin Shkreli, for the Dumbest Advice Ever on Drug Pricing
Feb 17 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.
Feb 18 / MotleyFool.com - Paid Partner Content
Investors Are Betting Big Against Intercept Pharmaceuticals. Are They Wrong?
Feb 17 / MotleyFool.com - Paid Partner Content
Five Major Myths about Options Trading
Feb 17 / Zacks.com - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Feb 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close70.31
Today’s open70.18
Day’s range69.71 - 70.79
Volume11,186,926
Average volume (3 months)10,517,782
Market cap$92.0B
Dividend yield2.98%
Data as of 4:14pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-25.41%
Earnings growth (next 5 years)-1.50%
Revenue growth (last year)-5.14%
P/E ratio6.5
Price/Sales3.20
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen-1.19-0.41%
AMGNAmgen+1.18+0.69%
ILMNIllumina Inc+2.07+1.28%
BIVVBioverativ Inc+3.35+7.60%
Data as of 4:14pm ET, 02/17/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$2.26
Annual revenue (last year)$30.4B
Annual profit (last year)$13.5B
Net profit margin44.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs